GalaExtra is an in-house research report featuring undervalued public companies primarily listed on the NASDAQ, NYSE, and TSX. We expect to expand this service to include opportunities with quality crypto speculations.
Our reports detail exciting undervalued companies in sectors with substantial growth potential such as Biotech, Fin-tech, Defense and many other sectors with unrealized profitability.
Our reports are easy to follow and make for engaging material for the sophisticated speculator.
Please consult with a licensed and qualified financial advisor before making investment decisions.
Sign up to receive priority delivery of these valuable reports right to your inbox.
Program Will Lend $10M to Detroit Minority Businesses
Find people with high expectations and a low tolerance for excuses. They'll have higher expectations for you than you have for yourself. Don't flatter...
Now Is the Time to Think About Your Small-Business Success
Find people with high expectations and a low tolerance for excuses. They'll have higher expectations for you than you have for yourself. Don't flatter...
Making sense of a questionable cannabis investment & acquisition tips
Deep dives into Entourage Health's upsized credit facility and acquisition tips based on Emerald X's purchase of MJBiz.
Read more...
Cannabis retailer Fire & Flower consolidating shares for Nasdaq listing
Canadian cannabis retail chain Fire & Flower is consolidating its shares on a 10-to-1 basis as part of a plan to list on the...
How Tilray-MedMen deal could impact either cannabis company's US aspirations
Last week, British Columbia-based Tilray (TLRY on Nasdaq, TSX), the second-largest Canadian licensed producer by market cap, announced a transaction to gain a substantial...
